Home › Attention Deficit Hyperactivity Disorder › NCT01246765

National Pregnancy Registry for Psychiatric Medications

Who can join

Ages 18 to 45 · Women · Healthy volunteers welcome

Inclusion Criteria:

* Pregnant women
* Age 18-45
* Subjects will be willing to participate over the phone
* Subjects will be able to provide informed consent

Exclusion Criteria:

* Women who have completed their pregnancy
* Women who are planning to become pregnant
* Women who are not taking any psychiatric medications and/or have no history of psychiatric illness

About the study

The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.

Sponsor: Massachusetts General Hospital · Participants: 5,000 · Started: 2008-11

Contact the study team

• Bryn Rediger · Phone: (617) 724-8020
• Lee Cohen, MD · Phone: (617) 724-8020

Official record on ClinicalTrials.gov — NCT01246765

Locations in the U.S.

Conditions

• Attention Deficit Hyperactivity Disorder

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.